题名 | Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial | 链接 | https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00309-0/abstract |
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00309-0/abstract |